Altered splicing and cytoplasmic levels of tRNA synthetases in SF3B1-mutant myelodysplastic syndromes as a therapeutic vulnerability

Myelodysplastic syndromes (MDS) are haematopoietic malignancies that are characterised by a heterogeneous clinical course. In recent years, sequencing efforts have uncovered recurrent somatic mutations within RNA splicing factors, including SF3B1, SRSF2, U2AF1 and ZRSR2. The most frequently mutated...

Descripción completa

Detalles Bibliográficos
Autores principales: Liberante, Fabio Giuseppe, Lappin, Katrina, Barros, Eliana M., Vohhodina, Jekaterina, Grebien, Florian, Savage, Kienan I., Mills, Kenneth Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390101/
https://www.ncbi.nlm.nih.gov/pubmed/30804405
http://dx.doi.org/10.1038/s41598-019-39591-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390101/
https://www.ncbi.nlm.nih.gov/pubmed/30804405
http://dx.doi.org/10.1038/s41598-019-39591-7

Ejemplares similares